Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2025 group results

Feb 13 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           10.77           10.04          11.40         5.70    
               (+7.3 pct)      (+7.5 pct)     (+5.9 pct)    (+5.5 pct) 
  Operating      343 mln         318 mln        270 mln      170 mln   
               (+7.7 pct)      (-38.7 pct)    (-21.3 pct)  (-38.5 pct) 
  Recurring      489 mln         364 mln        340 mln      200 mln   
               (+34.4 pct)     (-44.2 pct)    (-30.5 pct)  (-41.7 pct) 
  Net
  Net            337 mln         262 mln        220 mln      130 mln   
               (+28.6 pct)     (-40.8 pct)    (-34.7 pct)  (-48.2 pct) 
  EPS           59.26 yen       45.05 yen      38.77 yen    22.91 yen  
  Ann Div       50.00 yen       50.00 yen      50.00 yen               
  -Q2 Div       25.00 yen       14.00 yen      25.00 yen               
  -Q4 Div       25.00 yen       36.00 yen      25.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T

Recent news on Cosmo Bio

See all news